Obeticholic acid (OCA) is a potent bile acid derivative that activates FXR to reduce hepatic lipid synthesis and improve glucose and insulin sensitivity in patients with NAFLD.[37,107–109] OCA may also be used to treat atherosclerosis. This evidence concerns the gene NR1H4 and atherosclerosis.